Genitourinary experts will debate, vote on key strategies in
anticipation of publishing a final manuscript
MANALAPAN, N.J., Aug. 8, 2024 /PRNewswire-PRWeb/ -- Mashup
Media, LLC, is thrilled to announce their partnership with the
inaugural Advanced Urologic Cancer Consensus Conference (AUC3),
taking place January 2025 in
Miami, Fla.
Tremendous progress has been made in the
treatment of patients with urologic cancers, but experts believe
critical questions remain that are unable to be answered by robust
prospective clinical trials. AUC3 aims to address this scarcity of
information.
This dynamic, two-day live event will feature interactive
discussions and debate. Preselected panel members representing
multiple disciplines will vote on diagnostic and management
strategies for kidney and bladder cancer. Following the meeting,
conference directors and panel members will collaborate to develop
and draft the consensus guidelines manuscript for publication in a
peer-reviewed journal.
Tremendous progress has been made in the treatment of patients
with urologic cancers, but experts believe critical questions
remain that are unable to be answered by robust prospective
clinical trials. AUC3 aims to address this scarcity of
information.
Before the meeting, a hand-selected panel of international
experts will work with the conference directors to develop the
consensus questions using an iterative process. During the event,
the expert panel will present available data, then debate and vote
on each consensus question.
The meeting format will foster a comprehensive knowledge
exchange to define consensus guidelines that will better frame
discussions between patients with kidney and bladder cancer and
their physicians.
AUC3 follows a host of successful Mashup Media-driven events,
including Uromigos Live & Unplugged, The HemeOnc Pulse Live and
Advancements in Oncology: Today's Data for Tomorrow's Practice.
"We are excited to partner with AUC3 to create a long overdue
platform in the bladder and kidney cancer space that will have a
powerful impact on practicing clinicians," said Joe Palumbo, President and Chief Revenue Officer
at Mashup Media. "Producing innovative events and providing
opportunities to stimulate real-world health care outcomes is a
trademark of our organization," he added.
AUC3 will feature high-quality, interactive conversations with
key opinion leaders, including medical oncologists, radiation
oncologists, urologists, radiologists, pathologists, scientists,
investigators, support staff and patient advocates.
Stay tuned to GU Oncology Now for meeting updates.
About Mashup Media, LLC
Based in Manalapan, N.J.,
Mashup Media is a multimedia publishing company passionate about
providing health care professionals with a platform to further
publicize their work. Driven by data and analytics, Mashup Media
produces cutting-edge products that deliver content from trusted
sources and industry thought leadership. To learn more, visit
mashupmediallc.com.
About GU Oncology Now
GU Oncology Now is a robust platform that delivers current
genitourinary oncology-specific news, with the goal of informing
oncology decisions and improving patient outcomes. The website
highlights essential clinical content, providing health care
professionals with the opportunity to evaluate the latest clinical
trials, research and case studies. Other key features include
conference coverage, roundtable discussions and access to industry
podcasts. In addition to its powerful website, GU Oncology Now
leverages email and social media to highlight the best insights
from key opinion leaders in the field.
Media Contact
Claire Nowak-Foltz, Mashup Media,
1 2624241334, cnowak@mashupmd.com
View original content to download
multimedia:https://www.prweb.com/releases/mashup-media-to-partner-with-auc3-for-the-first-ever-consensus-meeting-on-kidney-bladder-cancer-management-302216569.html
SOURCE Mashup Media